Epidemiology of non-B clade forms of HIV-1 in men who have sex with men in the UK

AIDS

Volumn 24, Issue 15, 2010, Pages 2397-2401

  Fox, Julie ^a,c   Castro, Hannah ^b,c   Kaye, Steve ^a   McClure, Myra ^a   Weber, Jonathan N ^a   Fidler, Sarah ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

epidemiology; HIV infection; MSM; non B clade; UK

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CLADISTICS; CONTROLLED STUDY; DISEASE COURSE; ETHNIC DIFFERENCE; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; PRIORITY JOURNAL; RISK FACTOR; UNITED KINGDOM;

ADULT; ALGORITHMS; GREAT BRITAIN; HIV INFECTIONS; HIV-1; HOMOSEXUALITY, MALE; HUMANS; LOGISTIC MODELS; MALE; PREVALENCE; RISK FACTORS; RNA, VIRAL;

EID: 77957222650     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32833cbb5b     Document Type: Article

References (23)

1. Perrin L, Kaiser L, Yerly S. Travel and the spread of HIV-1 genetic variants. Lancet Infect Dis 2003; 3:22-27. (Pubitemid 36041785)
2. UNAIDS (http://www.unaids.org). HIV-1 Genetic Variability: Implications for the development of HIV vaccines. http:// www.unaids.org. [Accessed 5 October 2007]
3. Vidal N, Peeters M, Mulanga-Kabeya C, Nzilambi N, Robertson D, Ilunga W, et al. Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) groupMgenetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa. J Virol 2000; 74:10498-10507.
4. Tatt I, Barlow K, Clewley J, Gill N, Parry J. Surveillance of HIV-1 subtypes among heterosexuals in England and Wales, 1997-2000. J Acquir Immune Defic Syndr 2004; 36:1092-1099. (Pubitemid 38989376)
5. Expert Group of the Joint United Nations Programme on HIV/AIDS. Implications of HIV variability for transmission: scientific and policy issues. AIDS 1997; 11:1-15.
6. New HIV diagnoses by prevention group1, and probable world region of infection, UK: 2006 testing times. HIV and other sexually transmitted infections in the United Kingdom. http://www.hpa.org.uk/infections/topics-az/hiv-and-sti/ publications/AnnualReport/2007/chap2/AR-2007-%20Chap%202-HIV.pdf.
7. Fox J, Dustan S, Kaye S, McClure M and Fidler S. Incident non-B clade HIV-1 infection in white gay men infected in UK between 2000 and 2005 [abstract 03]. HIV Med 2008; 7:1-2.
8. Aggarwal I, Smith M, Tatt ID, Murad S, Osner N, Geretti AM, et al. Evidence for onward transmission of HIV-1 non-B subtype strains in the United Kingdom. J Acquir Immune Defic Syndr 2006; 41:201-209.
9. Semaille C, Barin F, Cazein F, Pillonel J, Lot F, Brand D, et al. Monitoring the dynamics of the HIV epidemic using assays for recent infection and serotyping among new HIV diagnoses: experience after 2 years in France. J Infect Dis 2007; 196:377-383. (Pubitemid 47093888)
10. Cuevas M, Fernandez-Garcia A, Sanchez-Garcia A, Gonzalez-Galeano M, Pinilla M, Sanchez-Martinez M, et al. Incidence of non-B subtypes of HIV-1 in Galicia, Spain: high frequency and diversity of HIV-1 among men who have sex with men. Euro Surveill 2009; 14:19411-19414.
11. Giuliani M, Montieri S, Palamara G, Latini A, Alteri C, Perno CF, et al. Non-B HIV type 1 subtypes among men who have sex with men in Rome, Italy. AIDS Res Hum Retroviruses 2009; 25:157-164.
12. UK Group on Transmitted HIV Drug Resistance. Time trends in primary resistance to HIV drugs in the United Kingdom: multicentre observational study. BMJ 2005; 331:1368-1371.
13. The UK Collaborative HIV Cohort Steering Committee. The creation of a large UK-based multicentre cohort of HIVinfected individuals: the UK Collaborative HIV Cohort (UK CHIC) study. HIV Med 2004; 5:115-124.
14. de Oliveira T, Deforche K, Cassol S, Salminem M, Paraskevis D, Seebregts C, et al. An automated genotyping system for the analysis of HIV-1 and other microbial sequences. Bioinformatics 2005; 21:3797-3800. (Pubitemid 41535530)
15. Gifford RJ, de Oliveira T, Rambaut A, Pybus OG, Dunn D, Vandamme AM, et al. Phylogenetic surveillance of viral genetic diversity and the evolving molecular epidemiology of human immunodeficiency virus type 1. J Virol 2007; 81:13050-13056. (Pubitemid 350156943)
16. Pandrea I, Robertson DL, Onanga R, Gao F, Makuwa M, Ngari P, et al. Analysis of partial pol and env sequences indicates a high prevalence of HIV type 1 recombinant strains circulating in Gabon. AIDS Res Hum Retroviruses 2002; 18:1103-1116. (Pubitemid 35191771)
17. Gao F, Robertson DL, Morrison SG, Hui H, Craig S, Decker J, et al. The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin. J Virol 1996; 70:7013-7029. (Pubitemid 26307416)
18. Tovanabutra S, Beyrer C, Sakkhachornphop S, Razak MH, Ramos GL, Vongchak T, et al. The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2000. AIDS Res Hum Retroviruses 2004; 20:465-475. (Pubitemid 38720959)
19. Alaeus A, Lidman K, Bjorkman A, Giesecke J, Albert J. Similar rate of disease progression among individuals infected with HIV-1 genetic subtypes A-D. AIDS 1999; 13:901-907. (Pubitemid 29240184)
20. Vasan A, Renjifo B, Hertzmark E, Chaplin B, Msamanga G, Essex M, et al. Different rates of disease progression of HIV type 1 infection in Tanzania based on infecting subtype. Clin Infect Dis 2006; 42:843-852. (Pubitemid 43363943)
21. Kaleebu P, French N, Mahe C, Yirrell D, Watera C, Lyagoba F, et al. Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda. J Infect Dis 2002; 185:1244-1250. (Pubitemid 34439131)
22. Baeten JM, Chohan B, Lavreys L, Chohan V, McClelland RS, Certain L, et al. HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads. J Infect Dis 2007; 195:1177-1180. (Pubitemid 46543449)
23. Geretti AM, Harrison L, Green H, Sabin C, Hill T, Fearnhill E, et al. on behalf of the UK Collaborative Group on HIV Drug Resistance and the UK Collaborative HIV Cohort Study. Clin Infect Dis 2009; 48:1296-1305.